Nurse Practitioner Role Improves Radiation Oncology Follow-Up Care, Patient Experience
A posttreatment program demonstrated that nurse practitioner-led follow-up visits can be an essential component of radiation therapy.
Prostate Cancer
With Rucaparib Approval, Prostate Cancer Joins the Precision Oncology Era
The FDA’s accelerated approval of the PARP inhibitor rucaparib brings clinical prostate oncology into the precision medicine era.
PARP Inhibitor Prolongs Overall Survival in mCRPC
An overall survival advantage with olaparib was particularly observed among patients with BRCA1 or BRCA2 alterations.
Greater Subcutaneous Fat Improves mCRPC Treatment Response
In a study of men with mCRPC receiving chemotherapy and maximal androgen ablation, those who had an objective response to treatment had a significantly higher subcutaneous adipose tissue index than those who did not.
HIFU Focal Ablation for PCa Offers Adequate Short-Term Cancer Control
In a study, men who underwent high-intensity focused ultrasound partial gland ablation for prostate cancer had excellent preservation of potency and continence.
Darolutamide Prolongs Overall Survival in nmCRPC
Darolutamide also improved secondary endpoints, including the time to pain progression, cytotoxic chemotherapy, and first symptomatic skeletal event.
Doubling of Radical Surgery Rates for High-Risk Prostate Cancer Reported
By 2016, radical prostatectomy use nearly equaled radiation therapy use for high-risk prostate cancer.
Oral Antiandrogens Found to Increase Dementia Risk
In a study, only androgen deprivation therapy with oral antiandrogens were associated with an increased risk for dementia and Alzheimer disease.
Prostate Cancer Surgery Delay Not Linked to Worse Oncologic Outcomes
Deferring radical prostatectomy for intermediate- and high-risk prostate cancer for several months does not increase the risk for adverse oncologic findings.
FDA Approves Blood-Based Test as Companion Diagnostic for Multiple Cancer Drugs
Using a blood sample, the test is able to analyze more than 300 cancer-associated genes for alterations.
-
Loading...
-
Loading...
Next post in General Oncology
